CannaTech Tel Aviv 2019 Returns April 1-3, 2019

ISRAEL: Israel’s CannaTech conference returns to Tel Aviv, the global capital of medical cannabis —  a place where innovative Israeli researchers and scientists, high tech experts and “Start-Up Nation” entrepreneurs have fused their knowledge and skills with other world leaders in the industry to develop cutting edge expertise.

iCANN logo final

The main events will take place at Trask, in the Tel Aviv Port on the Mediterranean Sea, from April 1-3, 2019.

The cannabis economy is the world’s fastest growing industry, with an outstanding track record of research and development and a significant contribution to a vast array of medical treatments. Economists foresee the potential overall market worth of cannabis related goods and products in the tens of billions of dollars in the next decade.

Companies, entrepreneurs, researchers, investors and other stakeholders will meet at the CannaTech Innovation Summit to connect and learn about the latest opportunities in the booming medical cannabis market as well as the newest cutting-edge technologies and research in the field.

Saul Kaye, CEO and founder of CannaTech and iCAN-Israel Cannabis said, “Now that Israel has legalized export of medical cannabis, local industry and Israel’s research institutions, already decades ahead of any cannabis R&D facilities in the world, will flourish and continue to create global partnerships with countries that are witnessing unprecedented demand.  Israel will be helping patients across continents obtain the world’s safest and most effective cannabis-based medicine and products, and I could not be prouder that Israel and CannaTech are leaders in this ecosystem.”

At CannaTech attendees will hear from and meet the industry’s most serious thought leaders and market disrupters from around the world.  Topics will include Ag-Tech, Regulation, Medical Research, Investment, Media/New Cannabis Communication, Innovation, Hemp and Sustainability.

To learn more about the CannaTech Tel Aviv Innovation Summit, purchase tickets and subscribe to event updates and speakers lists click here.  To learn about iCAN, the Summit’s organizers,  click here for the iCAN website.

Arcview Co-Hosts Hong Kong’s First Ever Cannabis Investor Symposium

CHINA: Hong Kong’s first-ever Cannabis Investor Symposium will take place on November 1, 2018 at the W Hotel. The one-day gathering is hosted by The Arcview Group, CannaTech and URI Capital Management.

The Cannabis industry is the fastest growing market in the world and the legal cannabis business is expected to generate $57 billion globally by 2027 as countries throughout the world continue to legalize its use and demand continues to grow exponentially.

The Hong Kong Symposium will focus on the global investment opportunity but is specially curated toward the Asian market.

The most powerful cannabis business leaders and investment experts from around the world will gather to discuss the burgeoning industry.

Keynote and panel discussions will cover Cannabis and China, The Cannabis Value Chain, Market Insights: Australasia, Public and Private Investment Opportunities, Risks and Regulations, World Cannabis Policy and more.

The event is designed for those looking to gain insight into investment opportunities in the global cannabis market, family offices, money managers, venture capital firms, private equity funds, and institutional investors.

Troy Dayton, CEO of The Arcview Group adds: “The worldwide cannabis market is exploding, and Asian investors are increasingly paying attention. Up until now, pioneering Asian investors have only been able to simply read about this fascinating industry. Not anymore. We are bringing the cannabis industry to them.”

Saul Kaye, CEO of CannaTech and iCAN said of the symposium, “The time has come for serious Asian investors to enter the market. The Hong Kong event will take place days after CannaTech Sydney, Australia’s first Medical Cannabis Summit. The region’s attitude is evolving quickly, particularly with respect to Medical Cannabis and the industry needs to learn more. Currently dominated by American and Canadian investors, the time is right for the Asian investment community to join this industry. We are thrilled to partner with Arcview and URI Fund on this important event.”

Uri Capital Management added: “Cannabis usage as a medicinal plant dates back in Chinese history for thousands of years. Medicinal cannabis research is rapidly progressing, and we need to redefine our attitude towards cannabis and hemp. Asia, more specifically China, is poised to leverage its unique advantages in Hemp and agriculture to become a dominant global leader. URI is proud to become the first Chinese financial conglomerate to focus on the Asian cannabis industry and will leverage the firm’s world class research and investment resources to lead the way.”

For more information about the Hong Kong Cannabis Symposium, click here.

 

 

 

 

Nova Scotia Liquor Taps Tilray For Adult-Use Cannabis Products

CANADA:  Tilray Canada announced that it has been selected by the Nova Scotia Liquor Corporation to receive an initial purchase order for adult-use cannabis. The purchase order would allow Tilray, one of fourteen cannabis producers selected by NSLC, to supply the province of Nova Scotia with a diverse array of cannabis products in anticipation of the launch of the adult-use market on October 17, 2018.

According to the release, Tilray intends to fulfill NSLC purchase orders through its affiliate High Park Holdings Ltd., which was formed to produce and distribute a broad-based portfolio of adult-use cannabis brands and products.
 
High park “We’re thrilled High Park will have the opportunity to supply the province of Nova Scotia with a safe, secure and reliable source of adult-use cannabis products,” said Adine Fabiani-Carter, Chief Marketing Officer at High Park. “Our intention is to deliver on the high expectations Nova Scotians have of us by cultivating and distributing a portfolio of world-class adult-use brands and products that will lead the market in quality, excellence and craftsmanship.”